How does a molecular freight elevator work?

Researchers from the University Hospital Bonn and the University of Bonn discover an important membrane transport mechanism in pathogenic bacteria: PD Dr Gregor Hagelueken (left) and Philipp Hendricks (right) are part of the research team.
Photo: Alessandro Winkler / University Hospital Bonn (UKB)

Important Membrane transport mechanism in pathogenic bacteria researched.

Some bacterial membrane transporters work almost like freight elevators to transport substances through the cell membrane into the interior of the cell. The transporter itself spans the bacterial membrane. Like a forklift, a soluble protein outside the bacterium transports the substance to the “elevator” and unloads its cargo there. The freight elevator transports it to the inside of the cell, in other words to another floor. Researchers at the University Hospital Bonn (UKB) and the University of Bonn, in collaboration with a team from the University of York, have now studied the interaction between the transporter and its soluble substrate binding protein.

Interestingly, they adapt precisely to each other during the transportation process. As this happens very quickly, the researchers virtually “blocked” the elevator by specifically inserting anchors, so-called disulphide bridges. This enabled them to prove that only the loaded “forklift” fits the “elevator” if it is on the right floor. This makes transportation really effective. The study has now been published in the journal “Nature Communications”.

Like all cells, bacteria are also surrounded by a cell membrane. This thin layer of lipids encloses nutrients, genetic material and proteins of the cell. However, certain substances must be able to pass through the membrane. For example, substances that help pathogens to evade the human body’s immune response. To this end, pathogenic bacteria such as Haemophilus influenzae have so-called ATP-independent periplasmic (TRAP) transporters. They have two very flexible transmembrane domains that span the cell wall. The pathogen Haemophilus influenzae uses the TRAP transporter to transport sialic acid from its environment into the cell interior, which is then incorporated into the bacterial cell wall. The small sugar molecule is very common in human tissue. “Once it is incorporated into the bacterial cell wall, the sialic acid acts like a camouflage cap for the bacteria. This allows them to hide from our immune system because it makes them look similar to the body’s own tissue,” says PD Dr. Gregor Hagelueken from the Institute of Structural Biology at the UKB. He is also a member of the Transdisciplinary Research Area (TRA) “Life & Health” and the Immunosensation2 Cluster of Excellence at the University of Bonn.

Protein catches substance like a Venus flytrap

The TRAP transporter is supported by an additional substrate binding protein (SBP), which searches for sialic acid outside the bacterial membrane. Once this “forklift” has found a sugar molecule, the SBP changes its shape and binds the sialic acid tightly. “This binding process can be compared to the snapping shut of a Venus flytrap,” says Philipp Hendricks, one of the first authors of the study and a doctoral student at the Institute of Structural Biology at the University of Bonn.

It has long been suspected that the TRAP transporter recognizes the closed form of the substrate binding protein. The Bonn researchers therefore investigated whether the opening and closing of the SBP and the upward and downward movement of the TRAP transporter are actually coupled to each other. Because these movements are very fast, Hagelueken’s team used what is known as disulphide engineering, a special biotechnological tool, to block the transporter. “We locked the ‘elevator’ on different floors, so to speak – either inside the cell or outside,” says first author Dr. Martin Peter. He was a postdoctoral researcher at the Institute of Structural Biology and is now a researcher at Heidelberg University.

Bacterial freight elevator made visible with fluorescence microscopy

In collaboration with the laboratory of Prof. Dr. Ulrich Kubitscheck at the Clausius Institute for Physical and Theoretical Chemistry at the University of Bonn, the researchers were able to incorporate the TRAP transporter into artificial membranes. Using single-molecule fluorescence microscopy, they were able to precisely observe the binding between the TRAP transporter and the “forklift” and thus watch them live at work. “Our experiments showed that the movements of the SBP and those of the transmembrane elevator are indeed coupled with each other,” says first author Jan A. Ruland, postdoctoral researcher at the Clausius Institute at the University of Bonn. Thus, the SBP in its closed state preferentially binds to the inward-facing membrane elevator and the “open” SBP to the outward-facing TRAP transporter. “These new insights into the mechanism of the transporter may help in the future to develop antibiotics that ensure that the elevators of bacteria get stuck. This would put an end to the game of hide-and-seek and our immune system could destroy the bacteria more easily,” summarizes Hagelueken from the UKB.

Publication: Martin F. Peter, Jan A. Ruland Yeojin Kim, Philipp Hendricks et al; Conformational coupling of the sialic acid TRAP transporter HiSiaQM with its substrate binding protein HiSiaP; Nature Communications;
DOI: https://doi.org/0.1038/s41467-023-44327-3

Press contact:
Dr. Inka Väth
Deputy Press Spokeswoman at the University Hospital Bonn (UKB)
Communications and Media Office at the University Hospital Bonn
Phone: (+49) 228 287-10596
E-mail: inka.vaeth@ukbonn.de

About Bonn University Hospital: The UKB treats around 500,000 patients per year, employs around 9,000 staff and has total assets of 1.6 billion euros. In addition to over 3,300 medical and dental students, a further 585 people are trained in numerous healthcare professions each year. The UKB is ranked first among university hospitals in NRW in the science ranking and in the Focus clinic list and has the third highest case mix index (case severity) in Germany. In 2022 and 2023, the F.A.Z. Institute recognized the UKB as Germany’s most desirable employer and training champion among public hospitals in Germany.

Wissenschaftliche Ansprechpartner:

Scientific contact:
PD Dr. Gregor Hagelueken
Institute of Structural Biology
University Hospital Bonn (UKB)
Immunosensation2 Cluster of Excellence & TRA “Life & Health” at University of Bonn
Phone: +49 228 287-51200
E-mail: hagelueken@uni-bonn.de

Originalpublikation:

Martin F. Peter, Jan A. Ruland Yeojin Kim, Philipp Hendricks et al; Conformational coupling of the sialic acid TRAP transporter HiSiaQM with its substrate binding protein HiSiaP; Nature Communications;

https://doi.org/10.1038/s41467-023-44327-3

http://www.ukbonn.de

Media Contact

Dr. Inka Väth Kommunikation und Medien
Universitätsklinikum Bonn

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

AI to improve brain cancer diagnosis, monitoring, treatment

Recommendations published in The Lancet Oncology call for good clinical practice of new technologies to modernize decades-old standard of care for brain cancer patients. An international, multidisciplinary team of leading…

AI tool ‘sees’ cancer gene signatures in biopsy images

AI tool reads biopsy images… To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a microscope. But to figure out…

Skull bone marrow expands throughout life

…and remains healthy during aging. Blood vessels and stromal cells in the bone marrow create an ideal environment for hematopoietic stem cells to continuously produce all blood cells. During aging,…